Sihuan Pharmaceutical Holdings Group Ltd. (0460.HK)
HKD 0.74
(2.78%)
HKD 0.74
(2.78%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -2.63 Billion CNY | -0.02% |
| 2022 | -2.63 Billion CNY | 42.74% |
| 2021 | -4.6 Billion CNY | -19.54% |
| 2020 | -3.84 Billion CNY | 24.5% |
| 2019 | -5.09 Billion CNY | -58.34% |
| 2018 | -3.21 Billion CNY | -287.07% |
| 2017 | -831.85 Million CNY | 65.32% |
| 2016 | -2.39 Billion CNY | -5.48% |
| 2015 | -2.27 Billion CNY | -73.01% |
| 2014 | -1.31 Billion CNY | 0.53% |
| 2013 | -1.32 Billion CNY | -71.43% |
| 2012 | -770.79 Million CNY | 75.51% |
| 2011 | -3.14 Billion CNY | 46.21% |
| 2010 | -5.85 Billion CNY | -854.77% |
| 2009 | -612.85 Million CNY | -85.05% |
| 2008 | -331.17 Million CNY | -32.27% |
| 2007 | -250.38 Million CNY | -870.92% |
| 2006 | -25.78 Million CNY | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | -2.92 Billion CNY | 0.0% |
| 2023 FY | -2.63 Billion CNY | -0.02% |
| 2023 Q4 | -2.63 Billion CNY | 0.0% |
| 2023 Q2 | -2.4 Billion CNY | 0.0% |
| 2022 FY | -2.63 Billion CNY | 42.74% |
| 2022 Q2 | -3.91 Billion CNY | 0.0% |
| 2022 Q4 | -2.63 Billion CNY | 0.0% |
| 2021 FY | -4.6 Billion CNY | -19.54% |
| 2021 Q2 | -3.81 Billion CNY | 0.0% |
| 2021 Q4 | -4.6 Billion CNY | 0.0% |
| 2020 Q4 | -3.84 Billion CNY | 0.0% |
| 2020 Q2 | -4.35 Billion CNY | 0.0% |
| 2020 FY | -3.84 Billion CNY | 24.5% |
| 2019 FY | -5.09 Billion CNY | -58.34% |
| 2019 Q2 | -4.92 Billion CNY | 0.0% |
| 2019 Q4 | -5.09 Billion CNY | 0.0% |
| 2018 Q4 | -3.21 Billion CNY | 0.0% |
| 2018 Q2 | -1.24 Billion CNY | 0.0% |
| 2018 FY | -3.21 Billion CNY | -287.07% |
| 2017 Q4 | -831.85 Million CNY | 0.0% |
| 2017 FY | -831.85 Million CNY | 65.32% |
| 2017 Q2 | -1.6 Billion CNY | 0.0% |
| 2016 Q2 | -2.67 Billion CNY | 0.0% |
| 2016 Q4 | -2.39 Billion CNY | 0.0% |
| 2016 FY | -2.39 Billion CNY | -5.48% |
| 2015 Q4 | -2.27 Billion CNY | 0.0% |
| 2015 Q2 | -2.28 Billion CNY | 0.0% |
| 2015 FY | -2.27 Billion CNY | -73.01% |
| 2014 Q2 | -1.42 Billion CNY | 0.0% |
| 2014 Q4 | -1.31 Billion CNY | 0.0% |
| 2014 FY | -1.31 Billion CNY | 0.53% |
| 2013 Q2 | -828.9 Million CNY | 0.0% |
| 2013 Q4 | -1.32 Billion CNY | 0.0% |
| 2013 FY | -1.32 Billion CNY | -71.43% |
| 2012 FY | -770.79 Million CNY | 75.51% |
| 2012 Q4 | -770.79 Million CNY | 0.0% |
| 2012 Q2 | -1.42 Billion CNY | 0.0% |
| 2011 Q4 | -3.14 Billion CNY | 0.0% |
| 2011 FY | -3.14 Billion CNY | 46.21% |
| 2011 Q2 | -4.96 Billion CNY | 0.0% |
| 2010 FY | -5.85 Billion CNY | -854.77% |
| 2010 Q4 | -5.85 Billion CNY | 0.0% |
| 2009 FY | -612.85 Million CNY | -85.05% |
| 2008 FY | -331.17 Million CNY | -32.27% |
| 2007 FY | -250.38 Million CNY | -870.92% |
| 2006 FY | -25.78 Million CNY | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Pak Fah Yeow International Limited | -258.7 Million HKD | -918.452% |
| Grand Pharmaceutical Group Limited | 2.03 Billion HKD | 229.673% |
| Extrawell Pharmaceutical Holdings Limited | 5.94 Million HKD | 44426.464% |
| Wai Yuen Tong Medicine Holdings Limited | 301.53 Million HKD | 973.781% |
| Qianhai Health Holdings Limited | -19.03 Million HKD | -13739.505% |
| Lee's Pharmaceutical Holdings Limited | 30.94 Million HKD | 8613.523% |
| Essex Bio-Technology Limited | -219.22 Million HKD | -1101.832% |
| Tongfang Kontafarma Holdings Limited | 256.16 Million HKD | 1128.546% |
| PuraPharm Corporation Limited | 377.54 Million HKD | 797.86% |
| SSY Group Limited | 1.71 Billion HKD | 253.763% |
| JBM (Healthcare) Limited | -7.39 Million HKD | -35509.745% |
| Jacobson Pharma Corporation Limited | 337.44 Million HKD | 880.805% |
| China Resources Pharmaceutical Group Limited | 50.97 Billion HKD | 105.168% |